These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19142970)

  • 1. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics.
    Uemura N; Nakanishi Y; Kato H; Saito S; Nagino M; Hirohashi S; Kondo T
    Int J Cancer; 2009 May; 124(9):2106-15. PubMed ID: 19142970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
    Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
    Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.
    Liu W; Yu ZC; Cao WF; Ding F; Liu ZH
    World J Gastroenterol; 2006 Jun; 12(24):3929-32. PubMed ID: 16804985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
    Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
    Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
    Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma.
    Sakai M; Suzuki S; Sano A; Tanaka N; Inose T; Sohda M; Nakajima M; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2012 Jun; 19(6):1911-7. PubMed ID: 22290569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Expression of PDHE1α Predicts Worse Clinical Outcome in Esophageal Squamous Cell Carcinoma.
    Zhong Y; Huang R; Li X; Xu R; Zhou F; Wang J; Fan H; Goscinski M; Zhang M; Wen JG; Nesland JM; Suo Z
    Anticancer Res; 2015 Oct; 35(10):5533-8. PubMed ID: 26408721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
    Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
    Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.
    Sedighi M; Aledavood SA; Abbaszadegan M; Memar B; Montazer M; Rajabian M; Gholamin M
    Asian Pac J Cancer Prev; 2016; 17(6):2781-5. PubMed ID: 27356690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
    Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches.
    Fu L; Qin YR; Xie D; Chow HY; Ngai SM; Kwong DL; Li Y; Guan XY
    Cancer; 2007 Dec; 110(12):2672-81. PubMed ID: 17960614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.
    Li K; Wang RW; Jiang YG; Zou YB; Guo W
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
    Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
    Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p12CDK2-AP1 is associated with tumor progression and a poor prognosis in esophageal squamous cell carcinoma.
    Hiyoshi Y; Watanabe M; Hirashima K; Karashima R; Sato N; Imamura Y; Nagai Y; Yoshida N; Toyama E; Hayashi N; Baba H
    Oncol Rep; 2009 Jul; 22(1):35-9. PubMed ID: 19513502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.